Clincosm LogoSign in Get a demo

Melanoma

Showing NaN - NaN of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Worldwide (Nivolumab, Ipilimumab, RO7247669)

Recruiting
  • Melanoma
  • Duarte, California
  • +20 more
Jan 24, 2023

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Placebos)

Active, not recruiting
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +209 more
Nov 14, 2022

Melanoma Trial in Worldwide (Ceralasertib, Durvalumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +75 more
Dec 5, 2022

Melanoma Trial in Worldwide (Nivolumab, Nivolumab + Relatlimab Fixed Dose Combination)

Recruiting
  • Melanoma
  • Nivolumab
  • Nivolumab + Relatlimab Fixed Dose Combination
  • Birmingham, Alabama
  • +185 more
Dec 3, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Placebo)

Active, not recruiting
Has Results
  • Melanoma
  • Pembrolizumab
  • Placebo
  • Tucson, Arizona
  • +158 more
Oct 31, 2022

Melanoma Trial in Tampa (CC-122, Nivolumab)

Completed
Has Results
  • Melanoma
  • Tampa, Florida
    H Lee Moffitt Cancer Center and Research Institute
Sep 27, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Melanoma Trial in Tampa (XL888, Vemurafenib)

Active, not recruiting
  • Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

Active, not recruiting
  • Urinary Bladder Cancer
  • +9 more
  • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
  • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
  • Miami, Florida
  • +10 more
Aug 9, 2022

Implementation National_001

Recruiting
  • Melanoma
    • Tampa, Florida
    • +8 more
    Aug 8, 2022

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022

    Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

    Terminated
    • Melanoma
    • +8 more
    • GEN-011
    • +3 more
    • Gilbert, Arizona
    • +7 more
    Jul 13, 2022

    Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

    Recruiting
    • Solid Tumor
    • +9 more
    • MEM-288 Intratumoral Injection
    • Tampa, Florida
    • +1 more
    Jun 27, 2022

    Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

    Terminated
    • Melanoma
    • +6 more
    • Scottsdale, Arizona
    • +13 more
    Jun 24, 2022

    Melanoma Trial in Worldwide (Nivolumab 3 mg/kg IV, Ipilimumab 1 mg/kg IV, Nivolumab 1 mg/kg IV)

    Completed
    Has Results
    • Melanoma
    • Nivolumab 3 mg/kg IV
    • +4 more
    • Aurora, Colorado
    • +56 more
    Jun 17, 2022

    Melanoma Trial in Tampa (Ipilimumab, Axitinib)

    Recruiting
    • Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 21, 2022

    Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)

    Active, not recruiting
    • Melanoma
    • +2 more
    • HBI-8000 in combination with nivolumab
    • Phoenix, Arizona
    • +5 more
    Jun 11, 2022

    Melanoma Trial in Tampa (Tavo, Nivolumab, OncoSec Medical Electroporation Therapy System)

    Recruiting
    • Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    May 31, 2022

    Unresectable And Metastatic Melanoma: The Optimize Study

    Completed
    • Melanoma
      • Muscle Shoals, Alabama
      • +65 more
      May 17, 2022

      Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)

      Recruiting
      • Liver Metastases
      • +10 more
      • DNX-2440
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute, Inc.
      Mar 28, 2022

      Melanoma Trial in Worldwide (Relatlimab, Nivolumab)

      Active, not recruiting
      Has Results
      • Melanoma
      • Relatlimab
      • Nivolumab
      • Tucson, Arizona
      • +126 more
      Mar 2, 2022